These drugs work similarly but differ in dosage and specific indications (uses). Research suggests that tirzepatide is more ...

FDA halts actions on makers of compounded drugs as it reviews decision to remove Eli Lilly's (LLY) weight loss drug ...

Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded ...

A pharmacist warns that off-brand Ozempic, Zepbound, and other weight loss products carry undisclosed risks for consumers.

Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...

Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide, from its ...